Novo Holdings A/S - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$92,044,178
+22.5%
3,377,7680.0%6.80%
+17.1%
Q2 2023$75,155,338
+2.7%
3,377,7680.0%5.81%
+20.3%
Q1 2023$73,162,455
+6.6%
3,377,7680.0%4.83%
+12.7%
Q4 2022$68,602,468
-19.6%
3,377,768
+1.5%
4.28%
+5.3%
Q3 2022$85,324,000
+42.0%
3,327,768
+31.7%
4.07%
+37.5%
Q2 2022$60,080,0002,526,4902.96%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders